![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, April 16, 2021 1:16:13 PM
I am writing to you with exciting news; ABMC is selling the Status COVID-19/Flu A+B combo test. Below and attached are some information on this product; please let me know if you might be interested, have any questions or wish to place an order.
• Status™ COVID-19/FLU A&B is an antigen test for use with nasopharyngeal swab specimens.
• Status™ COVID-19/FLU A&B test has been granted emergency use authorization (EUA) by
the FDA for use at the point-of-care setting. During the duration of the emergency this test
can be performed in a patient care setting that is operating under a CLIA Waiver, Certificate
of Compliance or Certificate of Accreditation.
1 test+ 1 specimen = 3 Results
TM
The additive power of Status COVID-19/Flu A&B
Learn More
• Sensitivity and Specificity
- COVID-19 - Sensitivity 93.9%, Specificity 100%
- Flu A - Sensitivity 91.4%, Specificity 95.7%
- Flu B - Sensitivity 87.6%, Specificity 95.9%
• FDA Emergency Use Authorization (EUA)
• Visually read in 15 minutes
• Flocked nasopharyngeal swab for superior specimen collection and patient comfort
I look forward to your feedback.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM